Hepatitis B Annual

REVIEW ARTICLE
Year
: 2007  |  Volume : 4  |  Issue : 1  |  Page : 72--106

Complementary and alternative therapies in the treatment of chronic hepatitis B


Jia-Ming Chang1, Kai-Ling Huang2 
1 Division of Research and Development, Development Center for Biotechnology, Xizhi City, Taipei County, 221, R.O.C, Taiwan
2 Department of Life Sciences and Institute of Biotechnology, National Tsing Hua University, Hsinchu, 30013, R.O.C, Taiwan

Correspondence Address:
Jia-Ming Chang
Division of Research and Development, Development Center for Biotechnology, Xizhi City, Taipei County, 221 R.O.C
Taiwan

Hepatitis B virus (HBV) infects approximately more than 350 million people worldwide, especially in Asia, Africa, southern Europe and Latin America. Except for interferon-α, most anti-HBV drugs are derived from the anti-herpes and anti-HIV drugs. Because of the high cost of hepatitis B medications, herbs-also called «SQ»complementary and alternative therapies«SQ» in modern Western science-are widely used for treatment of chronic hepatitis B in developing countries. Herbals confer their activities not only by inhibiting HBV secretion but also by building up immunity against viruses. After studying the anti-HBV mechanism of herbs, scientists were encouraged to find that novel anti-HBV drugs target viral secretion, whereas nucleoside analogues target viral polymerase. The complementary and alternative anti-HBV therapies published in scientific peer-reviewed journals are reviewed and discussed in this article.


How to cite this article:
Chang JM, Huang KL. Complementary and alternative therapies in the treatment of chronic hepatitis B.Hep B Annual 2007;4:72-106


How to cite this URL:
Chang JM, Huang KL. Complementary and alternative therapies in the treatment of chronic hepatitis B. Hep B Annual [serial online] 2007 [cited 2021 Dec 2 ];4:72-106
Available from: https://www.hepatitisbannual.org/article.asp?issn=0972-9747;year=2007;volume=4;issue=1;spage=72;epage=106;aulast=Chang;type=0